Your browser doesn't support javascript.
loading
The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.
Akkaif, Mohammed Ahmed; Sha'aban, Abubakar; Cesaro, Arturo; Jaber, Ammar Ali Saleh; Vergara, Andrea; Yunusa, Ismaeel; Jatau, Abubakar Ibrahim; Mohammed, Mustapha; Govindasamy, G Saravana; Al-Mansoub, Majed Ahmed; Sheikh Abdul Kader, Muhamad Ali; Ibrahim, Baharudin.
Afiliación
  • Akkaif MA; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
  • Sha'aban A; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. abuushaaban2@gmail.com.
  • Cesaro A; Department of Cardio-Thoracic and Respiratory Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Jaber AAS; Department of Clinical Pharmacy and Pharmacotherapeutics, Dubai Pharmacy College for Girls, 19099, Dubai, United Arab Emirates.
  • Vergara A; Department of Cardio-Thoracic and Respiratory Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Yunusa I; College of Pharmacy, University of South Carolina, Columbia, United States.
  • Jatau AI; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Tasmania, Australia.
  • Mohammed M; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
  • Govindasamy GS; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Kaduna, Nigeria.
  • Al-Mansoub MA; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
  • Sheikh Abdul Kader MA; Centre for Drug Research, Universiti Sains Malaysia, 11800, Penang, Malaysia.
  • Ibrahim B; Department of Cardiology, Penang General Hospital, 10990, Penang, Malaysia.
Inflammopharmacology ; 30(4): 1143-1151, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35701719

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Sistema Cardiovascular / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Malasia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Sistema Cardiovascular / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Malasia